➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Mallinckrodt
Harvard Business School
AstraZeneca
McKesson

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

Dichlorphenamide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for dichlorphenamide and what is the scope of patent protection?

Dichlorphenamide is the generic ingredient in two branded drugs marketed by Strongbridge Us and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for dichlorphenamide. Two suppliers are listed for this compound.

Recent Clinical Trials for dichlorphenamide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of RochesterPhase 3
National Institute of Neurological Disorders and Stroke (NINDS)Phase 3
Ohio State UniversityPhase 3

See all dichlorphenamide clinical trials

Pharmacology for dichlorphenamide
Medical Subject Heading (MeSH) Categories for dichlorphenamide

US Patents and Regulatory Information for dichlorphenamide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strongbridge Us KEVEYIS dichlorphenamide TABLET;ORAL 011366-002 Aug 7, 2015 RX Yes Yes   Start Trial   Start Trial   Start Trial
Strongbridge Us DARANIDE dichlorphenamide TABLET;ORAL 011366-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
AstraZeneca
Johnson and Johnson
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.